{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "9415315",
  "DateCompleted": {
    "Year": "1998",
    "Month": "01",
    "Day": "15"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "01",
    "Day": "29"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0969-7128",
      "JournalIssue": {
        "Volume": "4",
        "Issue": "10",
        "PubDate": {
          "Year": "1997",
          "Month": "Oct"
        }
      },
      "Title": "Gene therapy",
      "ISOAbbreviation": "Gene Ther"
    },
    "ArticleTitle": "Aberrant, noninfectious HIV-1 particles are released by chronically infected human T cells transduced with a retroviral vector expressing an interfering HIV-1 variant.",
    "Pagination": {
      "StartPage": "1085",
      "EndPage": "1092",
      "MedlinePgn": "1085-92"
    },
    "Abstract": {
      "AbstractText": [
        "The expression of the nonproducer F12-HIV-1 genome has been previously shown to protect the host cell from HIV superinfection. In order to estimate the efficacy of the F12-HIV genome as an anti-HIV reagent also in cells already infected, an HIV-1 chronically infected Hut-78 cell clone (D10) was superinfected with an amphotropic mouse/human pseudotype retrovirus whose genome expresses both the F12-HIV genome and the selection marker gene (i.e. the c-DNA of a truncated form of the nerve growth factor receptor, NGFr) under the control of F12-HIV 5'LTR. D10 cells homogenously expressing the F12-HIV genome (T-D10) released unaltered amounts of retrovirions whose infectivity was, however, dramatically impaired (from 9 x 10(3) in D10 to < 10(0.5). TCID50/ml in T-D10 supernatants). Electron microscopy showed that the morphology of retrovirions released by T-D10 cells was heavily altered, both in size and shape. Furthermore, no retrotranscription products were detectable in CD4 cells challenged with T-D10 retrovirions. For the first time, the block in the infectivity of HIV released from already infected cells through the expression of an anti-HIV retroviral vector was demonstrated. These data could have important implications both from a perspective of F12-HIV-based anti-HIV gene therapy and, in general, on the role that nonproducer and/or defective HIV could play 'in vivo' in HIV infection and AIDS pathogenesis."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Laboratory of Virology, Istituto Superiore di Sanit\u00e0, Rome, Italy."
          }
        ],
        "LastName": "Bona",
        "ForeName": "R",
        "Initials": "R"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "d'Aloja",
        "ForeName": "P",
        "Initials": "P"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Olivetta",
        "ForeName": "E",
        "Initials": "E"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Modesti",
        "ForeName": "A",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Modica",
        "ForeName": "A",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Geraci",
        "ForeName": "A",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Ferrari",
        "ForeName": "G",
        "Initials": "G"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Verani",
        "ForeName": "P",
        "Initials": "P"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Federico",
        "ForeName": "M",
        "Initials": "M"
      }
    ],
    "GrantList": [
      {
        "GrantID": "TGT06S01",
        "Acronym": "TI_",
        "Agency": "Telethon",
        "Country": "Italy"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Gene Ther",
    "NlmUniqueID": "9421525",
    "ISSNLinking": "0969-7128"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Cell Culture Techniques"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Chronic Disease"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Genetic Therapy"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Genetic Vectors"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Genome, Viral"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "HIV Infections"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "HIV-1"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "Retroviridae"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "Superinfection"
    },
    {
      "QualifierName": [
        "virology"
      ],
      "DescriptorName": "T-Lymphocytes"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "Viral Interference"
    },
    {
      "QualifierName": [
        "pathogenicity",
        "ultrastructure"
      ],
      "DescriptorName": "Virion"
    }
  ]
}